Now Accepting Late-Breaking Abstracts for Symposium 2024.
Abstracts must be received by 5 p.m. ET on Friday, May 10, 2024. Decisions will be sent to submitters by May 31, 2024
Abstracts must be received by 5 p.m. ET on Friday, May 10, 2024. Decisions will be sent to submitters by May 31, 2024
A late-breaking abstract must meet at least 1 of the following 3 criteria:
Abstracts previously submitted as part of the original Call for Abstracts will not be considered.
Symposium 2024 invites submissions of abstracts for early morning sessions, workshops, and panels, as well as oral and poster presentations related to the theme of “From Disruption to Opportunity: Embracing Change in Health Care” or that are of significant interest to producers and users of evidence-based information and advice on drugs and health technologies.
Questions may be sent by email to [email protected]
Presentations from all interested parties are welcome. These include:
Note: Some invited sessions and presentations may also be incorporated into the program.
Please note that presenters and panellists are responsible for all Symposium-related expenses, such as registration, accommodation, and travel.
Abstracts are accepted in either English or French. Simultaneous interpretation will be provided at plenary sessions.
Abstracts can be submitted in English or French but must be written in the language of your presentation. They must include the presentation’s purpose and intended audience and a brief description of the presentation. The abstract must be 250 words or less. Please attach a brief (50-word maximum) narrative biography and picture (JPEG format, minimum of 200KB) of each presenter.
Questions may be sent by email to [email protected]